Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 52,200 shares at $44.54 ($2.3M) on 2022-12-16, disclosed to the SEC on 2022-12-16.
Open-market sale of $2.3M ENTA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.59 | 7,800 | $340K | 14.5% |
| 2 | $44.54 | 8,597 | $383K | 16.3% |
| 3 | $44.54 | 8,597 | $383K | 16.3% |
| 4 | $45.49 | 13,603 | $619K | 26.4% |
| 5 | $45.49 | 13,603 | $619K | 26.4% |
| Total | $44.89 avg | 52,200 |
| $2.3M |
| 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |